Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126829961 | 12682996 | 1 | I | 20160816 | 20160825 | 20160825 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-067758 | BRISTOL MYERS SQUIBB | 43.00 | YR | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126829961 | 12682996 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | U | 9218 | ||||||||||
126829961 | 12682996 | 2 | SS | ONFI | CLOBAZAM | 1 | Unknown | U | 0 | ||||||||||
126829961 | 12682996 | 3 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126829961 | 12682996 | 1 | Product used for unknown indication |
126829961 | 12682996 | 2 | Product used for unknown indication |
126829961 | 12682996 | 3 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126829961 | 12682996 | Drug interaction | |
126829961 | 12682996 | International normalised ratio abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |